Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Diseases of poverty and the 10/90 Gap
Philip Stevens, International Policy Network, 12-1-04

The "10/90 Gap" is shorthand for the premise that only 10% of global pharmaceutical research funding is devoted to conditions accounting for 90% of the global disease burden. The rest goes to research on “lifestyle” diseases afflicting wealthy nations. This would be a damning accusation if it was true, but a new report from the Campaign for Fighting Diseases shows that the 10/90 Gap is a myth, and that it is often government policies in poor nations that deny their own citizens access to essential medicines.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000